Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma

Figure 1

Kaplan-Meier curves for (A, D) OS, (B, E) PFS and (C, F) time to response of all melanoma patients with > =2 cells and <2 CTCs in 4.5 ml of blood. (C) Only patients undergoing system therapies were analysed for treatment response, N = 17. Patients treated with the B-Raf inhibitor vemurafenib were analysed separately (D, E and F).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us